Research graph
References from Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia
10.1056/nejmoa1002315 · 2010 · External reference
Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension
10.1161/circulationaha.114.006979 · 2015 · External reference
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
10.1172/jci86249 · 2016 · External reference
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study
10.1161/circulationaha.112.000765 · 2013 · External reference
Rodent models of group 1 pulmonary hypertension
10.1007/978-3-642-38664-0_5 · 2013 · External reference
